Lopressor/adult indications and dosage

Lopressor®
Black Box Warning
Adult Indications and Dosage   FDA-Labeled Use   Off-Label Use
Pediatric Indications and Dosage   FDA-Labeled Use   Off-Label Use
Contraindications
Warnings
Adverse Reactions   Clinical Trials Experience   Postmarketing Experience
Drug Interactions
Use in Specific Populations   Pregnancy   Labor and Delivery   Nursing Mothers   Pediatric Use   Geriatric Use   Gender   Race   Renal Impairment   Hepatic Impairment   Females of Reproductive     Potential and Males   Immunocompromised Patients
Routes and Preparations   Routes   Preparations
IV Compatibility
Overdosage
Pharmacology   Mechanism of Action   Structure   Pharmacodynamics   Pharmacokinetics   Nonclinical Toxicology
Clinical Studies
How Supplied
Images   Drug Images   Package & Label Display Panel
Patient Information   Patient Information from FDA   Patient Information from NLM
Combined Alcohol Use
Look-Alike Drug Names
Drug Shortage Status
Price

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

FDA-Labeled Indications and Dosage (Adult)

Hypertension

Upon patient presentation: 3 IV boluses of 5 mg each at 2-minute intervals.

Fifteen minutes after full IV dose (15 mg): initiate 50 mg ORALLY every 6 hours for 48 hours

If unable to tolerate the full IV dose: initiate 25 to 50 mg ORALLY every 6 hours for 48 hours.

Lopressor may be used alone or in combination with other antihypertensive agents.

Angina Pectoris

Lopressor is indicated in the long-term treatment of angina pectoris.

Myocardial Infarction

Lopressor ampuls and tablets are indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality. Treatment with intravenous Lopressor can be initiated as soon as the patient’s clinical condition allows (see Dosage and Administration, Contraindications, and Warnings).